Antiretroviral regimens in elderly patients

Philippe Morlat

What should we focus on when selecting an antiretroviral regimen for an elderly patient?

Philippe Morlat, MD, PhD: The main thing will be, I repeat myself [see: Pending pharmacokinetic studies of antiretroviral drugs in the elderly], the problem of interactions. We have to avoid some antiretroviral drugs that have this problem of interacting with other drugs. We should not give them drugs that are boosted with components called cobicistat or ritonavir, which affect elimination of other drugs. We have to pay attention with these drugs. But even taking this into consideration, we can give them any antiretroviral therapy.

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.